This memo sheet presents the management modalities of the main dyslipidemias: isolated hypercholesterolaemia, mixed dyslipidaemia, isolated hypertriglyceridaemia and heterozygous familial hypercholesterolaemia. The treatment of these dyslipidaemias can only be considered with concomitant management of other modifiable factors of cardiovascular risk.
See also
Practice guidelines
06/12/2018
HAS opinions and decisions
06/12/2018
HAS opinions and decisions
30/03/2017
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
hR8EPhz1PD9JLQje